Amy Burroughs
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Amy L.
Burroughs is currently an Independent Director at Tenaya Therapeutics, Inc. since 2022.
Former roles include President, Chief Executive Officer & Director at Cleave Therapeutics, Inc. from 2019 to 2023; Chief Executive Officer & Director at Terns Pharmaceuticals, Inc. from 2025 to 2026; Independent Director at DiaMedica Therapeutics, Inc. from 2021 to 2023; Commercial Team Leader at Genentech, Inc.; Principal at Procter & Gamble Co.; Chief Commercial Officer & Head-Business Development at APT Pharmaceuticals, Inc. in 2009; and Principal at WholeHealth Living, Inc. and ePhysician, Inc. Education includes undergraduate studies at Dartmouth College and an MBA from Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.12.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 05.05.2026 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Vorstandsvorsitzender | 01.10.2023 |
| DIAMEDICA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.03.2023 |
ePhysician, Inc.
ePhysician, Inc. Packaged SoftwareTechnology Services Develops point-of-care software products that enable transferring of patient information via the Internet | Corporate Officer/Principal | - |
WholeHealth Living, Inc.
WholeHealth Living, Inc. Medical/Nursing ServicesHealth Services Operates outpatient healthcare facilities | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Procter & Gamble Co.
Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WholeHealth Living, Inc.
WholeHealth Living, Inc. Medical/Nursing ServicesHealth Services Operates outpatient healthcare facilities | Health Services |
ePhysician, Inc.
ePhysician, Inc. Packaged SoftwareTechnology Services Develops point-of-care software products that enable transferring of patient information via the Internet | Technology Services |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen